| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2400093586 |
PD-1 Antibody Combined with Neoadjuvant Chemotherapy for Ovarian Cancer Ethics Committee of The Obstetrics & Gynecology Hospital of Fudan University |
Ovarian Cancer |
Therapy Study |
Post-market |
2025-08-20 | 66 | Patient list |
| 284746 |
The Fourth Hospital of Hebei Medical University |
colorectal cancer |
Diagnostic Accuracy Test |
Post-market |
2025-08-20 | 63 | Patient list |
| 269121 |
Hubei cancer hospital |
Non-small cell lung cancer |
Therapy Study |
|
2025-08-05 | 115 | Patient list |
| ChiCTR2500102007 |
PLA General Hospital, Beijing |
breast cancer |
Therapy Study |
Premarket |
2025-07-08 | 147 | Patient list |
| ChiCTR2500102712 |
A Phase II Trial of adjuvant moderate hypofractionation after radical prostatectomy Chinese PLA General Hospital |
prostate cancer |
Therapy Study |
Premarket |
2025-07-08 | 131 | Patient list |
| ChiCTR2500096659 |
West China Hospital, Sichuan University |
Extensive-stage Small Cell Lung Cancer |
Therapy Study |
Premarket |
2025-05-23 | 257 | Patient list |
| ChiCTR2400086012 |
Affiliated Hospital of Guangdong Medical University |
gastric cancer |
Diagnostic Accuracy Test |
Post-market |
2025-05-12 | 189 | Patient list |
| ChiCTR2400086012 |
Affiliated Hospital of Guangdong Medical University |
gastric cancer |
Therapy Study |
Post-market |
2025-05-05 | 255 | Patient list |
| MR-52-24-033185 |
Affiliated Hospital of Zunyi Medical University |
Lung complications after lung cancer surgery |
Preention Study |
Premarket |
2025-02-25 | 263 | Patient list |
| none |
|
breast cancer |
|
|
2025-02-18 | 340 | Patient list |